12:10 PM EST - Avicanna Inc. : Has received a research licence from Health Canada. The Research Licence will allow Avicanna's research and development team to work with cannabinoid-based formulations and advanced pharmaceutical drug development at Avicanna's research and development headquarters located at the MaRS Discovery District in Toronto. Avicanna Inc.
shares T.AVCN are trading up $0.01 at $4.40.
